Older people in hospital with flu fared somewhat better if they had been vaccinated
Among more than 132,000 people aged 65 and over admitted to French hospitals with flu, those who had received that season's flu vaccine were less likely to need a breathing machine or to die in hospital. The differences were modest, the study is observational, and it is a preprint.
Flu vaccines are usually judged by one question: does the shot stop people from catching flu or from ending up in hospital? A second question gets less attention. When a vaccinated person does get flu badly enough to be admitted, is the illness milder than it would have been? This matters most for older adults, whose immune system responds less strongly to both infections and vaccines, and who account for most of the deaths from flu in Europe.
A French team has now looked at this question using the country's national health records. Their answer is a cautious yes: the vaccinated patients did somewhat better. The study is a preprint, meaning it has not yet been peer-reviewed, and it is an observational study, so it shows links, not proof that the vaccine caused the difference.
What they did
France's national health data system records almost every hospital stay, every reimbursed prescription and every death for more than 98% of the population. People aged 65 and over get their flu vaccine free with a voucher they take to a pharmacy, so the pharmacy records show who picked up a vaccine and when.
The researchers found every hospital admission of a person aged 65 or over with confirmed flu between October 2016 and December 2024. They left out the 2020–2021 season, when COVID-19 almost wiped out flu, and people living in nursing homes with their own pharmacies, whose vaccines would not show up in the records. That left 132,443 admissions: 72,852 (55%) in people vaccinated that season and 59,591 (45%) in people who were not.
The two groups were not alike. The vaccinated patients were older (82.3 versus 79.3 years on average) and more often had long-term illnesses. To make a fair comparison, the team weighted the data so that the groups matched on age, sex, chronic illnesses, social deprivation, where they lived, and other vaccinations, and then compared four outcomes: needing a breathing machine (mechanical ventilation through a tube), admission to intensive care, death in hospital, and any of these.
What they found
- Breathing machines: 2.9% of vaccinated and 4.3% of unvaccinated admissions needed one. After balancing the groups, vaccination was linked to a 12% lower risk.
- Death in hospital: the raw rates were almost the same (8.6% vaccinated, 8.3% unvaccinated), because the vaccinated patients were older and sicker. After balancing, vaccination was linked to a 10% lower risk.
- Intensive care: no clear difference in the chance of being admitted to intensive care once the groups were balanced.
- After intensive care: among patients who did reach intensive care, vaccinated ones had a 15% lower risk of dying and left hospital alive sooner (the typical time to discharge was two days shorter).
- Seasons differed. The links were clearest in the late 2010s. In the unusual 2021–2022 season, after flu had almost vanished during the pandemic, vaccinated and unvaccinated patients did about equally well.
What to keep in mind
- Observational, so links only. The authors note that the health records lack information on smoking, frailty, physical function and lab results, so differences between the groups that weren't measured could explain part of the result.
- Only people already in hospital. If vaccination changes who ends up in hospital in the first place, comparing only admitted patients can skew the picture, as the authors point out.
- Imperfect labels. Flu was identified from hospital diagnosis codes without lab results, and vaccination from pharmacy records, which may miss some shots given another way.
- Modest effects. The authors call the size of the associations "modest", smaller than in several earlier studies. More than nine in ten vaccinated patients had received the standard-dose vaccine; stronger vaccines for older people were rare in this group.
- Industry links. The work was co-funded by Sanofi, which makes flu vaccines; two authors work for the company, and Sanofi reviewed the manuscript before submission. The funders had no role in the analysis, according to the paper.
- Not yet peer-reviewed.
Why it matters
In this study, 45% of the flu admissions were in older people with no recorded flu vaccine that season, even though it is free for them in France. The study adds large-scale, real-world evidence that the vaccine may do more than prevent infection: in people who get seriously ill anyway, being vaccinated was linked to a lower chance of the worst outcomes. Effects of 10–15% are small for one patient, but across a whole population of older adults every winter, the authors argue, they could add up.